Cargando…
Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa
Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Future Medicine Ltd
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137175/ https://www.ncbi.nlm.nih.gov/pubmed/32273973 http://dx.doi.org/10.2217/hep-2020-0008 |
| _version_ | 1783518372326014976 |
|---|---|
| author | Abou-Alfa, Ghassan |
| author_facet | Abou-Alfa, Ghassan |
| author_sort | Abou-Alfa, Ghassan |
| collection | PubMed |
| description | Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa. |
| format | Online Article Text |
| id | pubmed-7137175 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2020 |
| publisher | Future Medicine Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-71371752020-04-09 Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa Abou-Alfa, Ghassan Hepat Oncol Interview Discussing the importance of patient advocacy and the advancement of systemic therapies for the treatment of liver cancer, we catch up with Hepatic Oncology’s latest editorial board member Ghassan Abou-Alfa. Future Medicine Ltd 2020-03-31 /pmc/articles/PMC7137175/ /pubmed/32273973 http://dx.doi.org/10.2217/hep-2020-0008 Text en © 2020 Ghassan Abou-Alfa This work is licensed under the Attribution-NonCommercial-NoDerivatives 4.0 Unported License (http://creativecommons.org/licenses/by-nc-nd/4.0/) |
| spellingShingle | Interview Abou-Alfa, Ghassan Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title | Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title_full | Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title_fullStr | Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title_full_unstemmed | Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title_short | Patient advocacy and the future of systemic therapies in liver cancer: an interview with Ghassan Abou-Alfa |
| title_sort | patient advocacy and the future of systemic therapies in liver cancer: an interview with ghassan abou-alfa |
| topic | Interview |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7137175/ https://www.ncbi.nlm.nih.gov/pubmed/32273973 http://dx.doi.org/10.2217/hep-2020-0008 |
| work_keys_str_mv | AT aboualfaghassan patientadvocacyandthefutureofsystemictherapiesinlivercanceraninterviewwithghassanaboualfa |